Discover our

Services for Media

A person's finger touches a screen.

Are you a media representative looking for content on Bayer? This section provides news, press photos and more.

News
September 09, 2026
Not intended for U.S. and UK Media

Bayer initiates Phase II study of investigational GIRK4 inhibitor in patients with atrial fibrillation

September 02, 2026

Bayer advances combined seed and crop protection pipeline and enters phase of blockbuster launches

August 30, 2026
Not intended for U.S. and UK Media – European Society of Cardiology (ESC) Congress 2026:

Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

NEWS OVERVIEW